# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 91-100 of 605 results.
Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer
Status: Not yet recruiting
Last Changed: Feb 24, 2020
First Received: Feb 24, 2020
Disease(s): Ovarian Cancer, Intraperitoneal Chemotherapy
Intervention(s): Intraperitoneal chemotherapy during surgery
Locations: Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier, France
An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION)
Status: Recruiting
Last Changed: Feb 21, 2020
First Received: Oct 09, 2018
Disease(s): Platinum-resistant Recurrent Ovarian Cancer
Intervention(s): olaparib+cediranib combination therapy, durvalumab + olaparib combination therapy, durvalumab + chemotherapy treatment, durvalumab + tremelimumab + chemotherapy treatment, durvalumab + tremelimumab + paclitaxel treatment
Locations: Seoul National University Hospital, Seoul, Korea, Republic of
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Samsung Medical Center, Seoul, Korea, Republic of
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
Status: Recruiting
Last Changed: Jan 09, 2020
First Received: May 10, 2016
Disease(s): Ovarian Cancer
Intervention(s): Pembrolizumab, Carboplatin, Paclitaxel
Locations: Medical College of Wisconsin and Froedtert Hospital, Milwaukee, Wisconsin, United States
SEntine Lymph Node in earLY Ovarian Cancer (SELLY)
Status: Recruiting
Last Changed: Mar 12, 2019
First Received: Jun 20, 2018
Disease(s): Sentinel Lymph Node, Ovarian Cancer Stage I
Intervention(s): Sentinel node detection
Locations: Nuovo Ospedale degli Infermi, Biella, Italy
Fondazione di Ricerca e Cura 'Giovanni Paolo II', Campobasso, Italy
Istituto Regina Elena IRCCS, Roma, Italy
Policlinico Universitario Agostino Gemelli, Roma, Italy
Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response
Status: Recruiting
Last Changed: Apr 30, 2019
First Received: Feb 05, 2019
Disease(s): Ovarian Cancer
Intervention(s): collection of blood, urine, tumor and ascite samples
Locations: Centre François BACLESSE, Caen, France
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study
Status: Recruiting
Last Changed: Jan 28, 2020
First Received: Mar 13, 2018
Disease(s): Ovarian Cancer
Intervention(s): Enzalutamide 40 MG
Locations: Hospital de Mar, Barcelona, Spain
Hospital Reina Sofia, Córdoba, Spain
Hospital Madrid Sanchinarro (CIOCC), Madrid, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Son Llatzer, Palma De Mallorca, Spain
... and 4 other locations.
Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
Status: Not yet recruiting
Last Changed: Mar 16, 2018
First Received: Mar 15, 2018
Disease(s): Recurrent, Platinum-resistant Ovarian Cancer
Intervention(s): Decitabine, Carboplatin, Pegylated Liposomal Doxorubicin, Gemcitabine, Paclitaxel
Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study
Status: Recruiting
Last Changed: Sep 16, 2019
First Received: Sep 16, 2019
Disease(s): BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Intervention(s): Olaparib tablets
Locations: Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Uro-Ginecologico, Napoli, Italy
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: Nov 27, 2017
Disease(s): Recurrent Ovarian Carcinoma
Intervention(s): Bevacizumab, Atezolizumab, Chemotherapy, Placebos
Locations: Kreiskliniken Altötting-Burghausen, Altötting, Germany
Klinikum Augsburg, Augsburg, Germany
Hochtaunus-Kliniken, Bad Homburg, Germany
Charité - Universitätsmedizin Berlin (CVK), Berlin, Germany
Helios Klinikum Berlin-Buch, Berlin, Germany
... and 56 other locations.
Intra-Peritoneal Local Anaesthetics in Ovarian Cancer
Status: Not yet recruiting
Last Changed: Aug 22, 2019
First Received: Aug 22, 2019
Disease(s): Ovarian Cancer
Intervention(s): Ropivacaine, Saline Solution
Locations: Karolinska Hospital, Solna, Stockholm, Sweden